169 related articles for article (PubMed ID: 36717657)
1. CD8
Viot J; Abdeljaoued S; Vienot A; Seffar E; Spehner L; Bouard A; Asgarov K; Pallandre JR; Renaude E; Klajer E; Molimard C; Monnien F; Bibeau F; Turco C; Heyd B; Peixoto P; Hervouet E; Loyon R; Doussot A; Borg C; Kroemer M
Cell Mol Immunol; 2023 Apr; 20(4):365-378. PubMed ID: 36717657
[TBL] [Abstract][Full Text] [Related]
2. TIGIT and PD1 Co-blockade Restores ex vivo Functions of Human Tumor-Infiltrating CD8
Ge Z; Zhou G; Campos Carrascosa L; Gausvik E; Boor PPC; Noordam L; Doukas M; Polak WG; Terkivatan T; Pan Q; Takkenberg RB; Verheij J; Erdmann JI; IJzermans JNM; Peppelenbosch MP; Kraan J; Kwekkeboom J; Sprengers D
Cell Mol Gastroenterol Hepatol; 2021; 12(2):443-464. PubMed ID: 33781741
[TBL] [Abstract][Full Text] [Related]
3. CD226 identifies functional CD8
Huang H; Huang Z; Ge J; Yang J; Chen J; Xu B; Wu S; Zheng X; Chen L; Zhang X; Jiang J
Front Immunol; 2023; 14():1150803. PubMed ID: 37056782
[TBL] [Abstract][Full Text] [Related]
4. Differential gene expression of tumor-infiltrating CD8
Saleh R; Sasidharan Nair V; Toor SM; Taha RZ; Murshed K; Al-Dhaheri M; Khawar M; Petkar MA; Abu Nada M; Al-Ejeh F; Elkord E
J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32948653
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of the density of tumor-infiltrating lymphocytes in colorectal cancer liver metastases.
Wang E; Shibutani M; Nagahara H; Fukuoka T; Iseki Y; Okazaki Y; Kashiwagi S; Tanaka H; Maeda K
Oncol Lett; 2021 Dec; 22(6):837. PubMed ID: 34712361
[TBL] [Abstract][Full Text] [Related]
6. Integrated single-cell and bulk sequencing analyses with experimental validation identify the prognostic and immunological implications of CD226 in pan-cancer.
Ma P; Sun W
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14597-14617. PubMed ID: 37580402
[TBL] [Abstract][Full Text] [Related]
7. Tumor-infiltrating CD226
Zhang Y; Zhao ZX; Gao JP; Huang YK; Huang H
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4381-4389. PubMed ID: 36107244
[TBL] [Abstract][Full Text] [Related]
8. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer.
Schweiger T; Berghoff AS; Glogner C; Glueck O; Rajky O; Traxler D; Birner P; Preusser M; Klepetko W; Hoetzenecker K
Clin Exp Metastasis; 2016 Oct; 33(7):727-39. PubMed ID: 27449756
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the prognostic value of CD4 T cell subsets expanded from tumor-infiltrating lymphocytes of colorectal cancer liver metastases.
Kroemer M; Turco C; Spehner L; Viot J; Idirène I; Bouard A; Renaude E; Deschamps M; Godet Y; Adotévi O; Limat S; Heyd B; Jary M; Loyon R; Borg C
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33229508
[TBL] [Abstract][Full Text] [Related]
10. Expression of the immune checkpoint molecules CD226 and TIGIT in preeclampsia patients.
Li C; Liu H; Duan Z
BMC Immunol; 2024 Feb; 25(1):12. PubMed ID: 38326745
[TBL] [Abstract][Full Text] [Related]
11. CD8
Wang M; Bu J; Zhou M; Sido J; Lin Y; Liu G; Lin Q; Xu X; Leavenworth JW; Shen E
Clin Immunol; 2018 May; 190():64-73. PubMed ID: 28893624
[TBL] [Abstract][Full Text] [Related]
12. Increased co-expression of PD1 and TIM3 is associated with poor prognosis and immune microenvironment heterogeneity in gallbladder cancer.
He X; Peng Y; He G; Ye H; Liu L; Zhou Q; Shi J; Fu S; Wang J; Zhou Z; Li W
J Transl Med; 2023 Oct; 21(1):717. PubMed ID: 37828574
[TBL] [Abstract][Full Text] [Related]
13. IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in Melanoma.
Chauvin JM; Ka M; Pagliano O; Menna C; Ding Q; DeBlasio R; Sanders C; Hou J; Li XY; Ferrone S; Davar D; Kirkwood JM; Johnston RJ; Korman AJ; Smyth MJ; Zarour HM
Clin Cancer Res; 2020 Oct; 26(20):5520-5533. PubMed ID: 32591463
[TBL] [Abstract][Full Text] [Related]
14. CD155/TIGIT signaling regulates the effector function of tumor-infiltrating CD8+ T cell by NF-κB pathway in colorectal cancer.
Li S; Ding J; Wang Y; Wang X; Lv L
J Gastroenterol Hepatol; 2022 Jan; 37(1):154-163. PubMed ID: 34734434
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of tumor-infiltrating lymphocytes detected by flow cytometry in colorectal cancer.
Hu Y; Zhao J; Shen Y; Zhang C; Xia Q; Zhang G; Wang B; Wei B; Yu R; Ma J; Guo Y
Int Immunopharmacol; 2022 Dec; 113(Pt A):109286. PubMed ID: 36252474
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral infiltrating lymphocytes correlate with improved survival in colorectal cancer patients: Independent of oncogenetic features.
Nazemalhosseini-Mojarad E; Mohammadpour S; Torshizi Esafahani A; Gharib E; Larki P; Moradi A; Amin Porhoseingholi M; Asadzade Aghdaei H; Kuppen PJK; Zali MR
J Cell Physiol; 2019 Apr; 234(4):4768-4777. PubMed ID: 30370522
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of immune-microenvironment in colorectal liver metastases resected after triplets plus a biologic agent: A pooled analysis of five prospective trials.
Moretto R; Corallo S; Belfiore A; Rossini D; Boccaccino A; Lonardi S; Centonze G; Morano F; Germani MM; Loupakis F; Morelli L; Urbani L; Brich S; Marmorino F; Prisciandaro M; Aprile G; Fassan M; Cillo U; Cattaneo L; Fontanini G; De Braud F; Falcone A; Milione M; Pietrantonio F; Cremolini C
Eur J Cancer; 2020 Aug; 135():78-88. PubMed ID: 32554314
[TBL] [Abstract][Full Text] [Related]
18. Co-expression of PD-1 with TIGIT or PD-1 with TIM-3 on tumor-infiltrating CD8
Meyiah A; Mahmoodi Chalbatani G; Al-Mterin MA; Malekraeisi MA; Murshed K; Elkord E
Int Immunopharmacol; 2023 Jun; 119():110207. PubMed ID: 37099940
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of CD8+ T-cells density in stage III colorectal cancer depends on SDF-1 expression.
Lalos A; Tülek A; Tosti N; Mechera R; Wilhelm A; Soysal S; Daester S; Kancherla V; Weixler B; Spagnoli GC; Eppenberger-Castori S; Terracciano L; Piscuoglio S; von Flüe M; Posabella A; Droeser RA
Sci Rep; 2021 Jan; 11(1):775. PubMed ID: 33436863
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8
Banta KL; Xu X; Chitre AS; Au-Yeung A; Takahashi C; O'Gorman WE; Wu TD; Mittman S; Cubas R; Comps-Agrar L; Fulzele A; Bennett EJ; Grogan JL; Hui E; Chiang EY; Mellman I
Immunity; 2022 Mar; 55(3):512-526.e9. PubMed ID: 35263569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]